Healthcare - Events

The International Conference on Cardiology and Cardiovascular Science will take place from March 26-28, 2026, in Singapore and online, providing a unique opportunity for medical professionals, academics, and industry leaders to engage in high-level discussions on cardiac health. With sessions in Cardiology Conferences 2026 covering everything from advancements in cardiac electrophysiology to the role of AI in diagnosing cardiovascular diseases, these Cardiology Conferences are set to shape the future of heart disease prevention and treatment. By attending Cardiology Conference, participants will benefit from exposure to the latest research, practical training sessions, and exclusive networking opportunities with top-tier cardiologists and medical innovators. The Cardiovascular Science Conf…

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers Squibb/Orbital Therapeutics. Validating LNPs as a stand-out delivery vehicle for cell and gene therapies! Returning to Boston in April 2026, the 5th LNP Formulation and Process Development Summit is an industry-led end-to-end meeting providing the latest scientific content to advance LNP development for a variety of payloads and therapeutic applications, from mRNA vaccines to next-generation cell and gene therapies. This is your one-stop shop to hear insights on LNP discovery, analytics, formulation, process development and large-scale manufacturing. With 3 focused streams, Analytical Development and…

EDUCATION IS OUR TOP PRIORITY!With education documentation becoming a way of life and the budget constraints facing many hospitals and institutions, in conjunction with the Society of Interventional Radiology (SIR) and the Association for Radiologic and Imaging Nursing (ARIN), AVIR strives to build an education program that meets and exceeds the expectations of our attendees. The AVIR Annual Scientific Meeting continues to provide an excellent venue for participation and marketing for our corporate sponsors. AVIR MISSIONis to grow, advance, and continue education in the area of vascular and interventional radiology and to promote professional growth and resources for AVIR members throughout the medical community.The AVIR is comprised of department managers, chief technologists, directors a…

Neuroimmunology is entering a defining moment. With the $470M buyout of Vigil's TREM2 asset, Ventus' NLRP3 inhibitor in phase 2a, and promising phase 3 BTKi readouts from Sanofi and Roche, the field is beginning to show encouraging signs of clinical viability in targeting neuroinflammation. Now the real race begins. Uncovering the next wave of mechanisms, biomarkers, and translational strategies that will move beyond today's successes and unlock new therapeutic frontiers in neurodegeneration and neuroimmune-driven psychiatric disease. The 8th Neuroimmunology Drug Development Summit is the industry's only meeting fully dedicated to advancing novel neuroinflammatory targets, uniquely bridging cutting-edge academic discovery with the practical lens of drug development. This year's expanded pr…

Thought Leader Texas is a premier gathering for executives, innovators, and industry leaders who want to stay ahead of fast-moving shifts in business, leadership, and organizational strategy. This summit brings together experts from across sectors to share fresh perspectives, practical insights, and proven approaches that help leaders navigate today’s most pressing challenges. Through keynote talks, panel discussions, and interactive sessions, attendees will explore themes such as leadership development, talent and culture, operational excellence, technology adoption, and long-term strategic growth. Each session is designed to offer actionable takeaways-clear ideas and tools executives can bring back to their organizations. The event also creates space for meaningful networking, allowing l…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

One foundation. Cross-functional strength. Elevated impact. For years, the question was: What do we build next? More sophisticated AI. More advanced engagement models. Wider access strategies. Each impressive. Each reaching higher. Then market winds shifted. New regulations arrived. Suddenly, the question changed: Can our foundations hold? Walls between functions preventing flexibility. Disconnected data infrastructure fragmenting insights. Inefficiencies becoming liabilities under pressure. Those walls aren't load-bearing, they're removable. That data infrastructure can reinforce decisions. And patient purpose? That's the force binding everything together. You must underpin your customer engagement strategy with reimagined data and infrastructure. You must reprioritise your launch plans t…

The conference features a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions including: Device Innovations for Large Volume and Novel Drug Product DeliveryAdvancing Sustainability in the Injectable Device IndustryPrimary Packaging: Ensuring Safe, Stable, and Biocompatible Combination ProductsPatient-Driven Device Design Date and Time: Monday, 27 April 2026 at 08:30 - Wednesday, 29 April 2026 at 17:00

Optimizing ADC Physiochemical, Potency, and Impurity Analytical Methods to Enhance Product Understanding, Quality and Assess DARs for Regulatory Submissions The 5th ADC Analytical Development Summit is the only dedicated platform for tackling the unique analytical complexities of ADC development, bringing together technical leaders to ensure a high-quality, regulatory-compliant ADC product. The ADC landscape is undergoing a rapid transformation with novel modalities like bispecifics, dual payload conjugates, and novel conjugates all push the boundaries of innovation, whilst more traditional ADCs are progressing their way through the pipelines - analytical teams are facing greater challenges in ensuring product quality and regulatory compliance than ever. The 5th ADC Analytical Development…

The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. With rapid advances in structural biology, computation, and screening, the race is on to validate new GPCRs, understand dynamic activation mechanisms, and develop assays that better predict therapeutic efficacy and guide smarter candidate selection. Returning as the only industry-led meeting dedicated to GPCR drug discovery, the 5th GPCR-Targeted Drug Discovery Summit features a jam-packed agenda featuring new expert voices, and fresh insights spanning the latest targets, tools, and therapeutic strategies. Join 80+ GPCR-focused leaders across biopharma to share insights, build collaborations, and accelerate ne…

Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson and Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, formulation and clinical efficacy. To shine a light on the progress of this field, the highly anticipated 3rd Peptide-Based Therapeutics Summit returns to Boston as the industry’s only dedicated platform to turbocharge the next generation of peptide discoveries through development and towards life-saving treatments. Gathering industry leaders including Parabilis Medicines, Circle Pharma, Abbvie, Merck, Chugai Pharmaceuticals and many more, this is your premium forum to explore: - Novel computational tools- Optimize analytical assays- Formulating cell-specific delivery methods- DMPK translatab…

Regulatory and governmental momentum is forcing change, fast: The Senate have recently cleared the FDA Modernization Act 3.0The FDA have developed a roadmap that’s abandoning animal testing for mAbsNIH have closed the door on animal-only grantsThe UK join the plan to phase out animal testing, announced by the Science Minster Lord Vallance Meanwhile, your pipelines are chasing novel targets that in vivo models can't predict. The 11th 3D Tissue Models Summit is where the industry comes to solve this. As the only industry-led forum dedicated to advancing organoids, organ-on-chip, and MPS, you'll connect with scientists from AbbVie, Novartis, Vertex, and many more who are validating these models, securing regulatory buy-in, and making them work at scale. The shift is happening, so make sure yo…

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.  

Scientex Conferences proudly presents the 4th International Conference on Primary Care and Public Healthcare, taking place on May 07–08, 2026, at Kuala Lumpur, Malaysia, with an additional webinar option available from May 21–22, 2026, for those unable to attend in person. This global academic forum brings together leading researchers, healthcare professionals, policymakers, and educators to discuss current trends, breakthrough research, and practical innovations in primary care and public health. The purpose of this event is to foster interdisciplinary collaboration, highlight new strategies for healthcare delivery, and support the global exchange of knowledge and expertise in public health and clinical care. Attendees will benefit from a diverse scientific program featuring keynote addre…

CPHI Middle East is a large-scale pharmaceutical event held in Riyadh, Saudi Arabia, connecting global and regional professionals in the pharmaceutical supply chain. The event brings together buyers, manufacturers, and suppliers from across the industry, from ingredients to finished products. It is a key platform for sourcing new business, gaining market insights, and fostering connections within the pharmaceutical sector in the Middle East and Africa. Time: 9:00 AM - 6:00 PM Venue Details: Riyadh Exhibition and Convention Center - Malham, Malham, Riyadh Province, 13380, Saudi Arabia

The past few years for the TCR community have been dynamic. Approvals have signalled a viable path to commercialization, while a wave of company closures highlight the deep-rooted challenges in the current development processes. The message is clear: success is not guaranteed at approval. Addressing manufacturing costs, durability and long-term commercial viability is now mission critical for developers of TCR-based cell and biologic therapies. Spanning the full therapeutic landscape, including TCR-T, TCR mimetics, TCR-TCEs and TCR bispecifics, the 7th TCR-Based Therapies Summit cuts through the noise to focus exclusively on the challenges most acutely impacting the TCR field today. Connect with and hear directly from senior leaders driving progress at the forefront of the field, including…

The 4th Nasal Formulation and Delivery Summit is uniting formulation, delivery, and product development leaders from across pharma and biotech to advance the development of safe, effective, and commercially viable intranasal therapies. As intranasal delivery gains validation across systemic, CNS, and emergency-use indications, the pressure to optimize formulations, align drug–device strategies, and generate predictive preclinical and clinical data has never been greater.  In an era of accelerating approvals, expanding modalities, and heightened regulatory scrutiny, teams must move beyond proof-of-concept to ensure intranasal programs are scalable, translatable, and fit for commercialization. Success now depends on solving formulation and delivery challenges early, while designing deve…

The Pharma Partnering Summit is an exclusive Life Sciences Industry event, with the aim to help companies expand their network and put together licensing deals, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing, Alliance Management, Research Collaborations, M&A and Investment. In addition to identifying products and partners as well as investors, the forum also serves to disseminate knowledge through expert speakers, for the best practices in the field of industry partnerships.